The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model

Herpes simplex virus (HSV) infections are common and can cause severe illness but no vaccine is currently available. The recent failure of subunit HSV vaccines has highlighted the need for vaccines that present a diverse array of antigens, including the development of next-generation live-attenuated...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:NPJ Vaccines
Main Authors: Bernstein, David I., Cardin, Rhonda D., Smith, Gregory A., Pickard, Gary E., Sollars, Patricia J., Dixon, David A., Pasula, Rajamouli, Bravo, Fernando J.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648054/
https://ncbi.nlm.nih.gov/pubmed/33298966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-020-00254-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares